documents: FDA-1997-N-0059-0001

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-1997-N-0059-0001 FDA FDA-1997-N-0059 Policy on Period of Marketing Exclusivity for Newly Approved Drug Products With Enantiomer Active Ingredients; Request for Comments Notice General Notice 1997-01-10T00:00:00Z 1997 1 1997-01-15T05:00:00Z 1997-03-18T04:59:59Z 2025-05-13T20:09:52Z 97-944 0 0 09000064805d02af

Links from other tables